Clearside Biomedical Stock Market Value
| CLSD Stock | USD 1.07 0.01 0.93% |
| Symbol | Clearside |
Clearside Biomedical Price To Book Ratio
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Clearside Biomedical. If investors know Clearside will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Clearside Biomedical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.45) | Revenue Per Share 0.112 | Quarterly Revenue Growth (0.91) | Return On Assets (0.44) | Return On Equity (13.10) |
The market value of Clearside Biomedical is measured differently than its book value, which is the value of Clearside that is recorded on the company's balance sheet. Investors also form their own opinion of Clearside Biomedical's value that differs from its market value or its book value, called intrinsic value, which is Clearside Biomedical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Clearside Biomedical's market value can be influenced by many factors that don't directly affect Clearside Biomedical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Clearside Biomedical's value and its price as these two are different measures arrived at by different means. Investors typically determine if Clearside Biomedical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Clearside Biomedical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Clearside Biomedical 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Clearside Biomedical's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Clearside Biomedical.
| 10/04/2023 |
| 11/27/2024 |
If you would invest 0.00 in Clearside Biomedical on October 4, 2023 and sell it all today you would earn a total of 0.00 from holding Clearside Biomedical or generate 0.0% return on investment in Clearside Biomedical over 420 days. Clearside Biomedical is related to or competes with Oric Pharmaceuticals, Lyra Therapeutics, Inhibrx, ESSA Pharma, Sensei Biotherapeutics, NextCure, and Nuvation Bio. Clearside Biomedical, Inc., a biopharmaceutical company, focuses on the revolutionizing the delivery of therapies to the... More
Clearside Biomedical Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Clearside Biomedical's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Clearside Biomedical upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 5.02 | |||
| Information Ratio | 0.0168 | |||
| Maximum Drawdown | 27.42 | |||
| Value At Risk | (8.40) | |||
| Potential Upside | 9.28 |
Clearside Biomedical Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Clearside Biomedical's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Clearside Biomedical's standard deviation. In reality, there are many statistical measures that can use Clearside Biomedical historical prices to predict the future Clearside Biomedical's volatility.| Risk Adjusted Performance | 0.0405 | |||
| Jensen Alpha | 0.0769 | |||
| Total Risk Alpha | (0.61) | |||
| Sortino Ratio | 0.0175 | |||
| Treynor Ratio | 0.1911 |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Clearside Biomedical's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Clearside Biomedical Backtested Returns
Clearside Biomedical appears to be dangerous, given 3 months investment horizon. Clearside Biomedical secures Sharpe Ratio (or Efficiency) of 0.0426, which signifies that the company had a 0.0426% return per unit of standard deviation over the last 3 months. We have found twenty-nine technical indicators for Clearside Biomedical, which you can use to evaluate the volatility of the firm. Please makes use of Clearside Biomedical's mean deviation of 3.77, and Risk Adjusted Performance of 0.0405 to double-check if our risk estimates are consistent with your expectations. On a scale of 0 to 100, Clearside Biomedical holds a performance score of 3. The firm shows a Beta (market volatility) of 1.09, which signifies a somewhat significant risk relative to the market. Clearside Biomedical returns are very sensitive to returns on the market. As the market goes up or down, Clearside Biomedical is expected to follow. Please check Clearside Biomedical's potential upside, rate of daily change, and the relationship between the sortino ratio and skewness , to make a quick decision on whether Clearside Biomedical's price patterns will revert.
Auto-correlation | -0.29 |
Weak reverse predictability
Clearside Biomedical has weak reverse predictability. Overlapping area represents the amount of predictability between Clearside Biomedical time series from 4th of October 2023 to 1st of May 2024 and 1st of May 2024 to 27th of November 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Clearside Biomedical price movement. The serial correlation of -0.29 indicates that nearly 29.0% of current Clearside Biomedical price fluctuation can be explain by its past prices.
| Correlation Coefficient | -0.29 | |
| Spearman Rank Test | -0.49 | |
| Residual Average | 0.0 | |
| Price Variance | 0.02 |
Clearside Biomedical lagged returns against current returns
Autocorrelation, which is Clearside Biomedical stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Clearside Biomedical's stock expected returns. We can calculate the autocorrelation of Clearside Biomedical returns to help us make a trade decision. For example, suppose you find that Clearside Biomedical has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Clearside Biomedical regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Clearside Biomedical stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Clearside Biomedical stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Clearside Biomedical stock over time.
Current vs Lagged Prices |
| Timeline |
Clearside Biomedical Lagged Returns
When evaluating Clearside Biomedical's market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Clearside Biomedical stock have on its future price. Clearside Biomedical autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Clearside Biomedical autocorrelation shows the relationship between Clearside Biomedical stock current value and its past values and can show if there is a momentum factor associated with investing in Clearside Biomedical.
Regressed Prices |
| Timeline |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Clearside Biomedical is a strong investment it is important to analyze Clearside Biomedical's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Clearside Biomedical's future performance. For an informed investment choice regarding Clearside Stock, refer to the following important reports:Check out Clearside Biomedical Correlation, Clearside Biomedical Volatility and Clearside Biomedical Alpha and Beta module to complement your research on Clearside Biomedical. For information on how to trade Clearside Stock refer to our How to Trade Clearside Stock guide.You can also try the Theme Ratings module to determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Clearside Biomedical technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.